Max Life Insurance increased its stake in Acutaas Chemicals Limited from 2.14% to 2.19% by purchasing 39,823 shares. This acquisition is valued at approximately ₹14.43 crore based on the share price of ₹3619.40.
A research and development-driven manufacturer of specialty chemicals, Acutaas Chemical produces Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients for new chemical entities and innovative drug formulations. The company also supplies materials for agrochemicals and fine chemicals, serving global pharmaceutical and chemical industries. Its distinctive strength lies in vertically integrated manufacturing capabilities and specialized compound development through rigorous in-house research and technical expertise.
Now branded Axis Max Life after Axis Bank took a controlling stake. Crossed Rs 1.5 lakh crore in AUM in April 2024 with over 20% YoY growth and has continued to compound. CIO Sachin Bajaj has over 25 years of investment experience and runs a multi-cap equity book across ULIP, par and non-par funds with a quality and growth tilt.
